DoseMeRx vs Epocrates
Epocrates is part of the athenahealth family per its about page and costs $24.99 per month or $179.99 per year, currency not stated, with a group plan for teams and residents and access through a student email. The vendor says it has served more than a million users since 1998. Undated user reviews on GetApp and Software Advice complain about subscription cost, sponsor ads at app open and paywalled features. A hospital pharmacy running Bayesian dosing and an individual clinician after a phone reference make different purchases. DoseMeRx is reached through a demo request, Epocrates through paid epocrates+ plans.
DoseMeRx sells Bayesian forecasting for high-risk drugs to hospital pharmacists. Its homepage testimonials, picked by the vendor, include an infectious diseases specialist reporting a 70% drop in kidney injury. The evidence page lists nine papers and an IDWeek 2019 poster, with outcome claims in the vendor's own summaries.
Drug info · Reviewed November 2, 2026
When to pick each one
DoseMeRx
- Bayesian forecasting for high-risk medications
- 24/7 support and staged set-up
Epocrates
- $24.99 per month, currency not stated
- Drug reference, calculators, disease guidance
- Student access via student email
Score
Each row shows points earned of points available under the published rubric.
DoseMeRx
35of 100
Epocrates
74of 100
| Dimension | DoseMeRx | Epocrates | Difference |
|---|---|---|---|
| EHR integrations (count) | 0 / 4.2 | 0 / 4.2 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 2.4 | 0 / 2.4 | 0 |
| Peer-reviewed papers | 14.7 / 21 | 14.7 / 21 | 0 |
| RCT / meta-analysis / systematic review | 0 / 6 | 3 / 6 | -3 |
| Funding & adoption signal | 3.9 / 15.6 | 15.6 / 15.6 | -11.7 |
| Pricing transparency | 3 / 6 | 6 / 6 | -3 |
| Years in market | 0 / 6 | 6 / 6 | -6 |
Scroll horizontally to see every column.
Pricing
DoseMeRx
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Only a demo request form is linked. |
Epocrates
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| epocrates+, monthly | $24.99 | n/a | Cancel anytime. |
| epocrates+, yearly | n/a | $179.99 | The page says Save 40% when subscribing annually. Trial and refund terms are not stated. |
Evidence
DoseMeRx
Peer-reviewed
4 PubMed records name DoseMeRx.
- [Free online software tools for precision dosing of vancomycin, and other drugs]. (opens in new tab)
- Evaluation of two model-based Bayesian approaches for vancomycin dosing in general hospitalized patients. (opens in new tab)
- Implementation of Vancomycin Therapeutic Monitoring Guidelines: Focus on Bayesian Estimation Tools in Neonatal and Pediatric Patients. (opens in new tab)
Epocrates
Peer-reviewed
4 PubMed records name Epocrates.
- Retrospective cohort observation on psychotropic drug-drug interaction and identification utility from 3 databases: Drugs.com®, Lexicomp®, and Epocrates®. (opens in new tab)
- Agreement of Different Drug-Drug Interaction Checkers for Proton Pump Inhibitors. (opens in new tab)
- Assessing accuracy and completeness of drug information in mobile apps compared with Micromedex®: An AI-based study in Thai online communities. (opens in new tab)
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | DoseMeRx | Epocrates |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | n/a | 1998 |
| HQ | US | US |
Scroll horizontally to see both columns.
Common questions
Open the full drug info comparison
Drug references (Lexidrug, Micromedex, Epocrates) and interaction checkers (Drugs.com, Medscape). Built for the clinician at the point of care.


